Inventor · disambiguated record
Peter David Johnson
Also filed as: JOHNSON PETER · JOHNSON PETER DAVID
26 granted patents·7 pending applications·170 citations·filing 2007–2022
96Inventor score
Files withCHDI FOUNDATION INC15SUMMIT THERAPEUTICS PLC4SUMMIT CORP PLC3WYNNE GRAHAM MICHAEL3ARMER RICHARD EDWARD1
Top patents by PatentIndex Score
33 records- 0196US8268878B2Compounds having CRTH2 antagonist activityARMER RICHARD EDWARD·Filed 2011·Granted Sep 18, 2012·58 cites·5 claims
- 0293US11344637B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2020·Granted May 31, 2022·3 cites·22 claims
- 0392US11059836B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2019·Granted Jul 13, 2021·8 cites·23 claims
- 0491US10479802B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Nov 19, 2019·8 cites·25 claims
- 0590US12258355B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2022·Granted Mar 25, 2025·1 cites·14 claims
- 0690US11992535B2Compounds and probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2020·Granted May 28, 2024·2 cites·39 claims
- 0790US10137211B2Probes for imaging Huntingtin proteinCHDI FOUNDATION INC·Filed 2016·Granted Nov 27, 2018·6 cites·40 claims
- 0890US7999119B2Compounds having CRTH2 antagonist activityOXAGEN LTD·Filed 2007·Granted Aug 16, 2011·14 cites·10 claims
- 0989US10765764B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2018·Granted Sep 8, 2020·4 cites·27 claims
- 1087US9428464B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCOURTNEY STEPHEN MARTIN·Filed 2012·Granted Aug 30, 2016·14 cites·3 claims
- 1184US10907197B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Feb 2, 2021·4 cites·12 claims
- 1284US8518980B2Treatment of Duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Granted Aug 27, 2013·10 cites·4 claims
- 1383US9260422B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2012·Granted Feb 16, 2016·7 cites·10 claims
- 1483US8501713B2Drug combinations for the treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Granted Aug 6, 2013·8 cites·6 claims
- 1581US11918662B2Heterocyclic compounds and imaging agents for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2021·Granted Mar 5, 2024·1 cites·8 claims
- 1681US11104691B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Aug 31, 2021·2 cites·21 claims
- 1781US8975416B2Antibacterial compoundsDAVIS PAUL JAMES·Filed 2009·Granted Mar 10, 2015·5 cites·32 claims
- 1877US9822058B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2013·Granted Nov 21, 2017·3 cites·24 claims
- 1977US9763925B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2016·Granted Sep 19, 2017·2 cites·7 claims
- 2077US9314456B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Apr 19, 2016·2 cites·3 claims
- 2174US10442782B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 15, 2019·1 cites·21 claims
- 2273US9278091B2Compounds for the treatment of Clostridium difficile associated diseaseSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Mar 8, 2016·2 cites·24 claims
- 2371US9649310B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted May 16, 2017·1 cites·12 claims
- 2469US11851446B2Probes for imaging Huntingtin proteinCHDI FOUNDATION INC·Filed 2021·Granted Dec 26, 2023·0 cites·9 claims
- 2569US8987308B2Compounds for the treatment of Clostridium difficile-associated diseaseSUMMIT CORP PLC·Filed 2012·Granted Mar 24, 2015·2 cites·15 claims
- 2668US9981918B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofTOLEDO SHERMAN LETICIA M·Filed 2012·Granted May 29, 2018·2 cites·3 claims
- 2759US2022339302A1Isoindolinone compounds and imaging agents for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2022·Application pending·0 cites
- 2853US2010048660A1Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Application pending·0 cites
- 2953US2017217983A2Compounds for the treatment of clostridium difficile associated diseaseSUMMIT THERAPEUTICS PLC·Filed 2016·Application pending·0 cites
- 3051US2010317607A1Use of compounds for preparing anti-tuberculosis agentsINFECTIOUS DISEASE RES INST·Filed 2008·Application pending·0 cites
- 3146US2010168072A1Drug Combinations for the Treatment of Duchenne Muscular DystrophyBIOMARIN IGA LTD·Filed 2008·Application pending·0 cites
- 3245US2014018320A1Treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
- 3345US2014011782A1Drug combinations for the treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter David Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →